Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicin

Cancer, 04/20/2012

IDH aberrations and IDH1 codon 105 SNP occur in about 30% of younger patients with acute myeloid leukemia (AML), mostly with diploid karyotype. Using high–dose ara–C–based induction regimens, the authors did not detect an association with outcome for any of the aberrations.

Print Article Summary Cat 2 CME Report